Apollo Endosurgery, Inc. to Present at the 12th Annual LD Micro Conference
December 02 2019 - 8:00AM
Business Wire
Apollo Endosurgery, Inc. ("Apollo") (Nasdaq: APEN), a global
leader in less invasive medical devices for gastrointestinal and
bariatric procedures, today announced that company management will
present at the 12th Annual LD Micro Main Event investor conference
at the Luxe Sunset Boulevard Hotel in Los Angeles, California, on
Tuesday, December 10, 2019. The presentation is scheduled for 12:00
PM Pacific Time. Investors interested in scheduling a meeting
should contact David Scher at david@ldmicro.com, Apollo Endosurgery
investor relations at mkreps@darrowir.com or visit the conference
website at www.ldmicro.com.
About Apollo Endosurgery, Inc.
Apollo Endosurgery, Inc. is a medical technology company focused
on less invasive therapies to treat various gastrointestinal
conditions, ranging from gastrointestinal defect repairs to the
interventional treatment of obesity. Apollo's device-based
therapies are an alternative to invasive surgical procedures, thus
lowering complication rates and reducing total healthcare costs.
Apollo's products are offered in over 80 countries today and
include the OverStitch™ Endoscopic Suturing System, the OverStitch
Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric
Balloon.
Apollo’s common stock is traded on Nasdaq Global Market under
the symbol "APEN". For more information regarding Apollo
Endosurgery, go to: www.apolloendo.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191202005179/en/
Apollo Endosurgery, Inc. Stefanie Cavanaugh, 512-279-5100
investor-relations@apolloendo.com
Darrow Associates Investor Relations Matt Kreps, 214-597-8200
mkreps@darrowir.com
Apollo Endosurgery (NASDAQ:APEN)
Historical Stock Chart
From Dec 2024 to Jan 2025
Apollo Endosurgery (NASDAQ:APEN)
Historical Stock Chart
From Jan 2024 to Jan 2025